{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-326034","form_type":"8-K","ticker":"ORIC","cik":"0001796280","company_name":"Oric Pharmaceuticals, Inc.","filed_at":"2021-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.177057+00:00","generated_at":"2026-06-28T10:08:40.054453+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"ORIC Pharmaceuticals appoints Angie You to board, Carl Gordon resigns","bullets":["Carl Gordon, Ph.D., CFA, resigned as director voluntarily, no disagreement with board.","Angie You, Ph.D., appointed as Class II director, term expires at 2022 annual meeting.","You is CEO of Amunix Pharmaceuticals; previously chief business officer at Sierra Oncology and Aragon.","She receives annual cash retainer of $35,000, committee fees, and stock option for 33,250 shares.","No reportable transactions under Item 404(a) between You and ORIC."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-326034","json":"https://secwatch.observer/filing/0001193125-21-326034.json","markdown":"https://secwatch.observer/filing/0001193125-21-326034.md","text":"https://secwatch.observer/filing/0001193125-21-326034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1796280/000119312521326034/0001193125-21-326034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1796280/000119312521326034/d241352d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T10:08:40.054453+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"992eb90aae","claim":"Carl Gordon resigned as director at Oric Pharmaceuticals, Inc..","evidence_excerpt":"On November 9, 2021, Carl Gordon, Ph.D., C.F.A. submitted his resignation as a director of ORIC Pharmaceuticals, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1796280/000119312521326034/0001193125-21-326034-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"director"}],"fact_type":"executive_change"},{"claim_id":"abf1fa9b87","claim":"Angie You was appointed as director at Oric Pharmaceuticals, Inc..","evidence_excerpt":"On November 9, 2021, the Board appointed Angie You, Ph.D. to serve as a Class II director, with a term expiring at the Company’s 2022 annual meeting of stockholders, as well as serve as a member of the Company’s Audit Committee and Nominating and Corporate Governance Committee.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1796280/000119312521326034/0001193125-21-326034-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}